DermTech
Latest round
- Series C
Last raised
- Nov 2017
Total raised
- $16M
Investors
- 2
About DermTech
DermTech, Inc. specializes in genomic testing services, focusing on melanoma detection through non-invasive methods. Their innovative solutions aim to enhance dermatological assessments and patient care. DermTech, Inc. was founded in 1996 in the US, focusing on genomic testing services. The company has evolved its business strategy over the years but does not have known significant pivots.87 per share. DermTech, Inc. offers genomic testing services, prominently featuring the DermTech Melanoma Test, which uses DermTech Smart Stickers for non-invasive sample collection from skin lesions. This test provides dermatologists with objective genomic data essential for assessing melanoma risk. The product is available without out-of-pocket costs for Medicare beneficiaries, with a customer base that includes dermatologists, primary care physicians, and medical institutions. The company generates revenue primarily through its genomic testing services, particularly the DermTech Melanoma Test, utilizing a transaction structure that engages healthcare providers, primarily through reimbursements from insurance providers like Medicare.
Who invested in DermTech
2 investors across 2 rounds
See all investors in DermTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DermTech
Who invested in DermTech?
DermTech has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DermTech raised?
DermTech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DermTech last raise money?
DermTech's most recent round on record is a Series C, in Nov 2017.
What does DermTech do?
DermTech is a biotechnology company.
Where is DermTech headquartered?
DermTech is headquartered in San Diego, US.
Which VCs invest in companies like DermTech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DermTech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like DermTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.